fenfluramine

North America

Canada (0)
No result.
United States (0)
No result.

Europe

Austria (0)
No result.
Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
FINTEPLA 2,2 MG/ML oral sol
120 ml, adapteris, 2×3 ml ir 2×6 ml geri
250 ml, adapteris, 2×3 ml ir 2×6 ml geri
360 ml, adapteris, 2×3 ml ir 2×6 ml geri
60 ml, adapteris, 2×3 ml ir 2×6 ml geria
Rx
Rx
Rx
Rx
oral
A08AA02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
FINTEPLA 2,2 MG/ML oral sol
120 ml, adapteris, 2×3 ml ir 2×6 ml geri
250 ml, adapteris, 2×3 ml ir 2×6 ml geri
360 ml, adapteris, 2×3 ml ir 2×6 ml geri
60 ml, adapteris, 2×3 ml ir 2×6 ml geria
EU/1/20/1491/002
EU/1/20/1491/003
EU/1/20/1491/004
EU/1/20/1491/001
CP
CP
CP
CP
18-12-2020
18-12-2020
18-12-2020
18-12-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (0)
No result.
Netherlands (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
FINTEPLA 2,2 MG/ML oral sol
-
Rx
-
A08AA02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
FINTEPLA 2,2 MG/ML oral sol
EU/1/20/1491
-
18-12-2020
Product
Pack
SPC
PIL
Company
FINTEPLA 2,2 MG/ML oral sol
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (0)
No result.
Poland (0)
No result.
Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (0)
No result.
Switzerland (0)
No result.